drug development

Getting to the Root of the Disease: Developing Drugs Against the Hard-to-Target Wnt Pathway
Getting to the Root of the Disease: Developing Drugs Against the Hard-to-Target Wnt Pathway
BioSpace
Wnt pathway
drug development
Flag link:
Adaptimmune and Astellas to Co-Develop Allogenic CAR-T and TCR T-Cell Therapies
Adaptimmune and Astellas to Co-Develop Allogenic CAR-T and TCR T-Cell Therapies
BioSpace
Adaptimmune
SPEAR-T
Astellas
CAR-T
cell therapy
drug development
Flag link:
Biogen Teams Up With Startup CAMP4 to Scout for New Neuro Drugs
Biogen Teams Up With Startup CAMP4 to Scout for New Neuro Drugs
Xconomy
Biogen
Neuroscience
CAMP4 Therapeutics
drug development
Flag link:
Pfizer and eFFECTOR Ink $507 Million Cancer Deal
Pfizer and eFFECTOR Ink $507 Million Cancer Deal
BioSpace
Pfizer
Effector
small molecule drugs
cancer
drug development
Flag link:
Fostering Oncology Product Development for Kids with Cancer
Fostering Oncology Product Development for Kids with Cancer
FDA Law Blog
pediatric
oncology
FDA
drug development
Flag link:
Drug developers take fresh aim at 'guided-missile' cancer drugs
Drug developers take fresh aim at 'guided-missile' cancer drugs
Reuters
cancer
oncology
drug development
antibody-drug conjugate
Flag link:
China’s CF PharmTech Raises $90M to Advance Respiratory Drug Development
China’s CF PharmTech Raises $90M to Advance Respiratory Drug Development
Xconomy
China
CF PharmTech
respiratory disease
drug development
Flag link:
Novo Holdings tweaks fund to take antibiotics deeper into the clinic
Novo Holdings tweaks fund to take antibiotics deeper into the clinic
Fierce Biotech
Novo Holdings
antibiotics
drug development
Flag link:
Biopharma has abandoned antibiotic development. Here’s why we did, too.
Biopharma has abandoned antibiotic development. Here’s why we did, too.
Endpoints
Octagon Therapeutics
drug discovery
drug development
antibiotics
Flag link:
Omega Funds Closes $438 Million Fund VI Aimed at the Life Sciences
Omega Funds Closes $438 Million Fund VI Aimed at the Life Sciences
BioSpace
Omega Funds
drug development
Flag link:
Elsevier gets FDA backing for ‘predictive toxicology’ project
Elsevier gets FDA backing for ‘predictive toxicology’ project
Pharmaforum
Elsevier
FDA
drug development
predictive toxicology
liver toxicity
Flag link:
Researchers Call on FDA to Rethink Guidance Allowing Use of Surrogate Outcomes
Researchers Call on FDA to Rethink Guidance Allowing Use of Surrogate Outcomes
RAPS.org
FDA
JAMA
infectious diseases
drug development
surrogate endpoints
Flag link:
Researchers ID 10 New Drug Targets for Aggressive Brain Cancer Glioblastoma
Researchers ID 10 New Drug Targets for Aggressive Brain Cancer Glioblastoma
BioSpace
R&D
glioblastoma
drug development
Flag link:
Why Scott Gottlieb, venture capitalist, sees opportunity in antibiotics
Why Scott Gottlieb, venture capitalist, sees opportunity in antibiotics
Endpoints
Scott Gottlieb
FDA
antibiotics
drug development
Flag link:
Biogen Alzheimer's Case Shows Danger of Trials Killing Good Drugs
Biogen Alzheimer's Case Shows Danger of Trials Killing Good Drugs
Yahoo/Guru Focus
Biogen
Alzheimer's disease
aducanumab
clinical trials
drug development
Flag link:
How influenza discoveries could inspire a universal vaccine and new treatments
How influenza discoveries could inspire a universal vaccine and new treatments
Fierce Biotech
drug discovery
infuenza
antivirals
drug development
vaccines
Flag link:
Cystic Fibrosis Foundation Licenses Experimental Compound to AbbVie
Cystic Fibrosis Foundation Licenses Experimental Compound to AbbVie
BioSpace
AbbVie
cystic fibrosis
drug development
Flag link:
Public funds help late-stage development of about 25% of new drugs, study finds
Public funds help late-stage development of about 25% of new drugs, study finds
Endpoints
drug development
public funding
Flag link:
Still too little progress on antibiotic resistance, says O’Neill report update
Still too little progress on antibiotic resistance, says O’Neill report update
Pharmaforum
antibiotics
antibiotic resistance
drug development
Flag link:
Distorted Drug Patents: Does the U.S. Legal System Steer Researchers Away From Drugs that Take a Long Time to Develop?
Distorted Drug Patents: Does the U.S. Legal System Steer Researchers Away From Drugs that Take a Long Time to Develop?
FDA Law Blog
patents
innovation
drug development
FDA
Flag link:

Pages